BRIEF published on 03/10/2025 at 13:04, 1 year 6 months ago BlackRock reduces its stake in ARKEMA Actions Asset Management Participation BlackRock ARKEMA
PRESS RELEASE published on 03/10/2025 at 12:59, 1 year 6 months ago Franchissement de seuil Déclaration de franchissement de seuil par BlackRock Inc. pour ARKEMA. Baisse à 4,81% du capital et 3,85% des droits de vote Déclaration Franchissement De Seuil Baisse BlackRock Inc. ARKEMA
BRIEF published on 02/26/2025 at 08:35, 1 year 6 months ago Arkema Expands PVDF Production in North America Sustainability North America Lithium-ion Batteries ARKEMA PVDF Expansion
BRIEF published on 02/26/2025 at 08:35, 1 year 6 months ago Arkema étend sa production de PVDF en Amérique du Nord Durabilité Batteries Lithium-ion Amérique Du Nord ARKEMA Extension PVDF
PRESS RELEASE published on 02/26/2025 at 08:30, 1 year 6 months ago Inside Information / Other news releases Arkema to increase PVDF capacity by 15% in North America with $20 million investment in Kentucky plant to meet demand in lithium-ion batteries, semiconductor, and cable markets North America Investment Capacity Expansion ARKEMA PVDF
PRESS RELEASE published on 02/26/2025 at 08:30, 1 year 6 months ago Informations privilégiées / Autres communiqués Arkema augmente de 15% sa capacité de PVDF en Amérique du Nord pour soutenir la demande croissante en résines de haute performance, semi-conducteurs et batteries lithium-ion Investissement Amérique Du Nord ARKEMA Capacité PVDF
BRIEF published on 02/25/2025 at 10:29, 1 year 6 months ago Arkema Conducts Share Buyback Transactions Share Buyback EU Regulations ARKEMA Paris Market 2025 Transactions
BRIEF published on 02/25/2025 at 10:29, 1 year 6 months ago Arkema procède à des opérations de rachat d'actions Rachat D'actions ARKEMA Règlements De L'UE Marché De Paris Transactions 2025
PRESS RELEASE published on 02/25/2025 at 10:24, 1 year 6 months ago Inside Information / Other news releases Arkema discloses trading in own shares from 17 to 21 February 2025, in compliance with regulations. Total of 22,500 shares repurchased at a weighted average price of 81.5923. Details on Arkema website Share Buyback Trading Own Shares ARKEMA Weighted Average Price
PRESS RELEASE published on 02/25/2025 at 10:24, 1 year 6 months ago Informations privilégiées / Autres communiqués Arkema annonce les transactions sur actions propres effectuées du 17 au 21 février 2025 dans le respect de la réglementation financière. Consultez le lien pour plus d'informations Actions Propres Réglementation Financière Transactions Investisseurs ARKEMA
Published on 09/11/2026 at 04:00, 8 hours 15 minutes ago Torq Announces Debt Settlement and Corporate Update
Published on 09/10/2026 at 22:25, 13 hours 50 minutes ago Pathfinder Ventures Announces Appointment of Mickey Perret as Chief Executive Officer
Published on 09/10/2026 at 15:20, 20 hours 55 minutes ago MicroVision to Preview Next-Generation Lidar-Based Perception Platform at IAA Transportation 2026
Published on 09/10/2026 at 15:00, 21 hours 15 minutes ago All Randomized Pediatric Patients to Continue in the Single-Blind Extension Phase of Jaguar Health's Pivotal Clinical Trial of Crofelemer for Microvillus Inclusion Disease (MVID) with Intestinal Failure (IF)
Published on 09/11/2026 at 11:43, 32 minutes ago Skyborn reaches Financial Close on the Gennaker offshore wind farm project
Published on 09/11/2026 at 11:35, 40 minutes ago EQS-Adhoc: Correction of a release from 10/09/2026, 19:35 CET/CEST - United Internet AG: Group subsidiaries 1&1 AG and IONOS Group SE launch transformation programs
Published on 09/11/2026 at 11:30, 45 minutes ago Galimedix Therapeutics to present functional feasibility data from Phase 2 eDREAM study in geographic atrophy at 26th EURETINA Congress
Published on 09/11/2026 at 10:15, 2 hours ago TCMA Receives Two National Awards, Highlighting Thailand’s Cement Industry Progress Towards Net Zero 2050
Published on 09/11/2026 at 07:00, 5 hours 15 minutes ago Transparantiekennisgeving van Baltisse Groep
Published on 09/11/2026 at 07:00, 5 hours 15 minutes ago BIOPHYTIS ANNOUNCES COMPLETION OF €5.3 MILLION CAPITAL INCREASE TO FUND ITS PHASE 2 TRIAL IN OBESITY
Published on 09/11/2026 at 07:00, 5 hours 15 minutes ago BIOPHYTIS ANNONCE LA RÉALISATION D’UNE AUGMENTATION DE CAPITAL DE 5,3 MILLIONS D’EUROS DESTINÉE À FINANCER SON ESSAI DE PHASE 2 DANS L’OBÉSITÉ
Published on 09/10/2026 at 19:30, 16 hours 45 minutes ago Availability of the 2026 Interim Financial Report
